Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03399396 · ClinicalTrials.gov registry record · NA
Increasing HPV Vaccination in Community-Based Pediatric Practices
A NA study, sponsored by Pamela Hull.
- Completed
- Registry status
- NA
- Development phase
- 420
- Enrollment target
NCT03399396: Completed NA study, sponsored by Pamela Hull.
NCT03399396 is a NA study that has completed, run by Pamela Hull. The registered enrollment target is 420 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03399396, a NA study, has completed, sponsored by Pamela Hull.
- COMPLETED
- Registry status
- NA
- Development phase
- 420 participants
- Enrollment target
Study Summary
The central goal of this study is to identify the optimal approach to implementing an evidence-based practice facilitation (PF) intervention for the uptake and completion of HPV vaccine among adolescents receiving care in the community, guided by implementation science theory. AIM 1: Determine the clinical effectiveness and cost-effectiveness of two modalities for delivering a multi-component PF intervention to increase HPV vaccination initiation and completion in community-based pediatric practices. The investigators will compare the traditional In-person Coaching PF modality to a lower-resource Web-Based Coaching PF modality. The primary patient outcome is HPV vaccination. The investigators will also examine and compare the sustainability of practice changes on vaccination rates and the effects over time for each intervention modality. AIM 2. Understand mechanisms of why the PF intervention may work better for some pediatric practices than others for HPV vaccination. The investigators will examine theory-based determinants at the organizational, provider, and patient levels that may mediate (explain) or moderate (change) the effects of the PF intervention on vaccination outcomes.
Primary Outcome
Percentage of active patients ages 13-17 who completed the HPV vaccine series before 13th birthday
Interventions
- BEHAVIORAL Practice facilitation for HPV vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2018-02-21 |
| Est. Completion | 2021-02-28 |
| Phase | NA |
What the finished NCT03399396 record still lists
NCT03399396 is an interventional study that assigns participants to a tested intervention. The registered 420 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 1 intervention - of which Practice facilitation for HPV vaccine is the first listed.
NCT03399396 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03399396 about?
NCT03399396 is a clinical study titled "Increasing HPV Vaccination in Community-Based Pediatric Practices". The central goal of this study is to identify the optimal approach to implementing an evidence-based practice facilitation (PF) intervention for the uptake and completion of HPV vaccine among adolescents receiving care in the community, guided by implementation science theory. AIM 1: Determine the ...
What is the current status of trial NCT03399396?
This trial is currently completed. It is a NA study. The enrollment target is 420 participants. The study started on 2018-02-21. Estimated completion is 2021-02-28.
What interventions are being tested in trial NCT03399396?
The interventions under investigation include: Practice facilitation for HPV vaccine (BEHAVIORAL).
Who is sponsoring clinical trial NCT03399396?
This trial is sponsored by Pamela Hull, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03399396's enrollment target sits among peer trials
420 239th of 2000 higher than 1,761 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
- NCT04149743 · 420 participants · NA
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI